NEW TOPICS

■October 16, 2018: Intrudaction Sir Run Run Shaw
Hospital, Zhejiang University School of Medicine

Profile of the Center for Cerebrospinal Fluid Hypovolemia Treatment of Sir Run Run Shaw
Hospital, Zhejiang University School of Medicine

The Center for Cerebrospinal Fluid Hypovolemia Treatment of Sir Run Run Shaw Hospital
(hereinafter referred to as SRRSH), Zhejiang University School of Medicine, is the earliest instituted medical center for cerebrospinal fluid (CSF) hypovolemia treatment established in China. Dr. He Feifang who is a center figure of the center studied in Japan at Okayama University Medical School in 2006 and established diagnostic criteria for CSF hypovolemia and performed surgery for correction of CSF leakage for the first time in China. Since then, he is the medical doctor who has promoted these treatment strategies.
Dr. He Feifang obtained the Sasagawa Medical Fellowship of the National Hygiene and Health
Commission of China (former Ministry of Health of China) in 2005 and studied at Okayama
University Medical School in 2006, during which he received training in treatment for chronic pain diseases at Okayama University Pain Center and provided treatment by medication and minimally invasive surgery for conditions including cancer, neuropathic pain and diseases including spontaneous CSF leakage. Since coming back to China in 2007, he has filled a void in treatment in this area by taking the lead in performing surgical operations related to spontaneous CSF leakage across China. For a long time, he worked in close coordination with many medical institutes in Japan, the United States and other countries and pain centers in China to put their efforts into the treatment of CSF leakage-related diseases caused by intracranial hypotension as well as into the establishment of “specialty outpatient departments for intracranial hypotension” and “spontaneous
CSF leakage surgery centers,” thereby allowing them to accept, examine and perform operations on patients with spontaneous and secondary CSF leakage nationwide and beyond boundaries.
As there is an inconsistency in etiology, time course of disease progression and characteristics of imaging findings of CSF leakages caused by intracranial hypotension among patients, the doctor has prepared minimally invasive surgery plans suitable for individual patients. So far he has already provided safe and effective minimally invasive surgeries to 800 patients with CSF leakage caused by intracranial hypotension from more than 20 provinces, cities and autonomous districts nationwide,
allowing him to gain a great deal of clinical experience.
In response to receiving multiple invitations from scientific conferences and medical institutes at home and abroad, Dr. He Feifang has given explanations and demonstrations of surgical operations related to CSF hypovolemia. His activities include the following: a poster presentation at the 2012
Asia-Pacific Region of Orofacial Pain, a poster session at the 2015 6th Association of Southeast Asia
Pain Societies Conference (Manila, Philippines), a symposium report at the 2016 Annual Meeting of CSF Hypovolemia Society (Tokyo, Japan), a poster session in the World Congress of Anaesthesiologists (Hong Kong) and a symposium report at the 2017 Annual Meeting of CSF Hypovolemia Society (Saitama, Japan). At the same time, he has worked actively to organize scientific conferences in China to invite internationally prominent scholars and deliver academic lectures. He had Professor Shinichi Ishikawa, chairman of the CSF Hypovolemia Society in Japan,
hold a forum and deliver a lecture at the SRRSH of Zhejiang University School of Medicine in 2016,and had a group comprising Shinichi Ishikawa, chairman of the CSF Hypovolemia Society in Japan,and Nakai, representative of the Association of Supporting Whiplash Injury Patients in Japan, attend a forum and lecture held at the SRRSH of Zhejiang University School of Medicine in 2017, where“China-Japan Cerebrospinal Fluid Hypovolemia Society” was established. Two organizations, the CSF Hypovolemia Society in Japan and the Association of Supporting Whiplash Injury Patients in Japan, placed emphasis on treatment of patients with CSF fluid hypovolemia in China. Ongoing
interactions helped expand the number of associates, which resulted in significant implications in promoting the progress of medical institutions and scientific standards on a global scale regarding
minimally invasive surgeries for treatment of CSF leakage caused by intracranial hypotension.
The Center for Cerebrospinal Fluid Hypovolemia Treatment, the SRRSH of Zhejiang University
School of Medicine, is able to markedly reduce the incidence of nervous system complications,
including compression of the spinal cord, adhesiolysis of the epidural space, hemorrhage and
hematoma formation of the epidural space and intracranial subdural hemorrhage by using every operative procedure, including “intraoperative imaging techniques for epidural space,” “minimally invasive epidural replacement by segmental catheter placement at high levels of the spinal cord,”and “replacement for CSF leakage in an extensive area.”
In China, the age of the Internet and medical care have arrived at high speeds and the CSF leakage surgery center of SRRSH of Zhejiang University School of Medicine is the only leading institution in China for surgeries to address CSF leakage. Until now, most Chinese have not fully understood the CSF fluid hypovolemia caused by intracranial hypotension, thereby leading to many cases of incorrect diagnosis, excessive conservative treatment and postponed surgical operations in clinical
settings. By using every measure, including media in the Hygiene Control Sector, the Internet and medical societies to publicize the superiority of surgical treatment of diseases caused by CSF leakage, the mentality of medical institutions, health personnel and patients will change to understanding and accepting the basis of the surgical and medical treatment. At the same time, the basis of correlated clinical treatment will be established with the aim of promoting the quick recovery of patients with CSF fluid hypovolemia.

October 16, 2018
Translated from Chines into Japanese by Miho Yamamoto

■April 1, 2017: Insurance Coverage for Epidural Blood Patch Therapy Starts

■January 20, 2016: On the 20th of the month, the “Central Social Insurance Medical Council” (Chuikyo) which is an advisory council for the Minister of Health, Labour and Welfare, approved coverage for epidural blood patch therapy, which is effective for cerebrospinal fluid hypovolemia causing symptoms of headache, etc., due to the leaking of cerebrospinal fluid, based on the results of a study by the Advanced Medical Conference. It was officially decided in the report issued in mid-February.

1月20日の中央社会保険医療協議会総会の様子


■Submitted signature list (signed by 173,052 people) to Minister Shiozaki of the Ministry of Health, Labour and Welfare on December 24, 2015. The Minister gave the account, “I will positively respond to your long-standing cordial activities.”

3月17日議員会館 公明党脳脊髄液減少症PT主催 脳脊髄液減少症の会議にて3月17日議員会館 公明党脳脊髄液減少症PT主催 脳脊髄液減少症の会議にて


■Cerebrospinal Fluid Hypovolemia Study Group held by Shimane
Prefecture: March 26, 2017
Lecturer: Dr Eiji Moriyama Director of the Department of Neurosurgery
Fukuyama Medical center

■Cerebrospinal Fluid Hypovolemia Study Group held by Fukuoka
Prefecture: March 22, 2017
Lecturer: Professor Shigeru Nishizawa, Department of neurosurgery, University Of Occupational and Environmental Health

■16th Annual Meeting of the Japan CFS Hypovolemia Society March 4~5, 2017

Chairman of the Society:
Shinichi Ishikawa
平成27年4月5日平成27年4月5日
(Chief of Pain Clinic, Anesthesiology, Japanese Red Cross Society Himeji Hospital)


■Cerebrospinal Fluid Hypovolemia Study Group held by Wakayama
Prefecture: March 3, 2017
Lecturer: Doctor Yasuo Ota, Acting Hospital Director, Sumiya Orthopedic Hospital

平成27年3月3日


■Cerebrospinal Fluid Hypovolemia Study Group held by Ishikawa
Prefecture: February 25, 2017 
Lecturer: Dr Norimistu Nakagawa Director of the Department of Neurosurgery  
Meimai chou Hospital

2月25日


■Cerebrospinal Fluid Hypovolemia Study Group held by Kagawa
Prefecture: February 12, 2016 
Lecturer: Dr Eiji Moriyama Director of the Department of Neurosurgery
Fukuyama Medical center

2月25日


■Cerebrospinal Fluid Hypovolemia Study Group held by Nagasaki
Prefecture: February 9, 2016
Lecturer:Dr Shinichi Goto Chief Anesthesiologist The Japanese Red Cross Society Nagasaki Genbaku Hospital

2月25日


■Cerebrospinal Fluid Hypovolemia Study Group held by Kagawa
Prefecture: November 6, 2016 
Lecturer: Dr Eiji Moriyama Director of the Department of Neurosurgery
Fukuyama Medical center

11月6日


■Cerebrospinal Fluid Hypovolemia Study Group held by Shizuoka
Prefecture: September 3, 2016
Lecturer:Professor Masamichi Shinonaga, Department of neurosurgery, International University of Health and Welfare Atami Hospital

9月3日


■Cerebrospinal Fluid Hypovolemia Study Group held by Yamaguchi
Prefecture: August 7, 2016
Lecturer: Dr Sadahiro Nomura Neurosurgery, Yamaguchi University School of Medicine

8月7日


■Cerebrospinal Fluid Hypovolemia Study Group held by Tottori
Prefecture: July 24, 2016
Lecturer: Dr Yoshizo Inagaki  Professor, Division of Anesthesiology and Critical Care Medicine, Department of Surgery, Tottori University Faculty of Medicine

7月24日


■Cerebrospinal Fluid Hypovolemia Study Group held by Aichi
Prefecture: May 27, 2016
Lecturer: Dr Akira Ikeda Acting Hospital Director Cyukyo Hospital

7月24日


■16th Annual Meeting of the Japan CFS Hypovolemia Society Chairman of the Society: Koichi Takahashi

7月24日
March 16-17, 2016: A total of more than 200 participants Many subjects (Brain surgery, orthopedic surgery, neurology, anesthesiology/pain clinic, ophthalmology and otolaryngology, psychosomatic medicine, urology, and anatomy), etc.